Clinical trial
Dactinomycin in Treating Patients With Persistent or Recurrent Gestational…
NCT00003688 · Gynecologic Oncology Group, Other · Completed
Key facts
| NCT number | NCT00003688 |
|---|---|
| Title | Dactinomycin in Treating Patients With Persistent or Recurrent Gestational Trophoblastic Neoplasia |
| Official title | Pulse Actinomycin-D as Salvage Therapy for Failed Low Risk Gestational Trophoblastic Neoplasia |
| Lead sponsor | Gynecologic Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Gestational Trophoblastic Tumor |
| Intervention type | Biological |
| Interventions | dactinomycin |
| Start date | Oct 1, 1999 |
| Primary completion | Sep 1, 2006 |
| First posted | Jan 27, 2003 |
| Last update posted | Jun 10, 2013 |
| Countries | Norway, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: